CNO Financial Group 3Q 2026: Revenue $1.09B, EPS $1.71 — 10-Q Summary
1分未満で読めます
CNO Financial Group’s revenue declined year over year, while net income rose. Higher insurance product margins and investment income not allocated to product lines supported earnings; lower investment results weighed on revenue, while the absence of the prior-year impairment charge also aided the comparison.
Financial Highlights
| Metric | Current quarter | Prior year quarter | YoY change |
| Revenue¹ | $1.09B | $1.19B | (8.6%) |
| Net income² | $161.1M | $23.1M | 597.4% |
| Diluted EPS³ | $1.71 | $0.24 | 612.5% |
¹ Reported as “Total revenues”. ² Reported as “Net income”. ³ Reported as “Net income”.
Business Highlights
- Insurance margins: Total insurance product margin increased to $333.0 million from $300.5 million; annuity and life margins rose, while health margin declined.
- Investment income: Investment income not allocated to product lines rose to $68.1 million from $39.5 million, reflecting higher alternative investment results and increased FHLB and FABN spread income.
- Actuarial review: The annual review had a net favorable $56.3 million impact on pre-tax operating earnings and a net favorable $36.0 million impact on net income.
- 2026 outlook: Full-year operating earnings per diluted share guidance rose to $5.05-$5.15; expected expense ratio narrowed to 18.6%-18.8%.
Original SEC Filing: CNO Financial Group, Inc. [ CNO ] - 10-Q - Nov. 05, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.